Guido Rasi and Luis Salaices were selected in the LSIPR 50 2016 publication for their influence on the life sciences industry. Rasi and Luis Salaices were featured in the government and policy section, as LSIPR reports.
Name: Guido Rasi
Organisation: European Medicines Agency
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Guido Rasi, Luis Salaices, European Medicines Agency, CRISPR gene-editing technology, International Union for the Protection of New Varieties of Plants,